MAC inhibitors suppress mitochondrial apoptosis

Area of Science:

• Cell Biology
• Biochemistry
• Pharmacology

Background:

• The mitochondrial apoptosis-induced channel (MAC) is crucial for intrinsic apoptosis, mediating cytochrome c release.
• MAC opening is a key commitment step in programmed cell death.
• Inhibiting MAC could represent a therapeutic strategy to prevent apoptosis.

Purpose of the Study:

• To identify and characterize compounds that can directly close MAC.
• To evaluate the efficacy of these compounds in suppressing apoptosis in cellular models.

Main Methods:

• Recombinant Bax protein was used to assess compound efficacy in blocking fluorescein release from liposomes.
• Compounds were tested for their ability to directly close MAC.
• Apoptosis was induced in FL5.12 cells via IL-3 deprivation or staurosporine treatment.
• Cytochrome c release and apoptotic markers were monitored.

Main Results:

• Several compounds were identified that irreversibly closed MAC at low concentrations (IC50: 19–966 nM).
• These compounds effectively inhibited cytochrome c release.
• The tested compounds suppressed the onset of apoptotic markers induced by IL-3 deprivation or staurosporine.

Conclusions:

• A direct link exists between MAC activity, cytochrome c release, and apoptotic cell death.
• The mitochondrial apoptosis-induced channel (MAC) is a viable therapeutic target for preventing apoptosis.